Understanding Factors in Group B Streptococcus Late-Onset Disease

References

• EdwardsMS, NizetV, BakerCJ. Group B streptococcal infections. In: Remington and Klein’s Infectious Diseases of the Fetus and Newborn Infant. 8th ed. Elsevier; 2016:411–456.
   Google Scholar
• DhudasiaMB, FlanneryDD, PfeiferMR, PuopoloKM. Updated guidance: prevention and management of perinatal group B Streptococcus infection. Neoreviews. 2021;22(3):e177–e188. doi:10.1542/neo.22-3-e17733649090
   PubMedGoogle Scholar
• VeraniJR, McGeeL, SchragSJ; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B Streptococcal disease–revised guidelines from CDC, 2010. MMWR Recomm Rep. 2010;59(RR–10):1–36.
   PubMedGoogle Scholar
• Di RenzoGC, MelinP, BerardiA, et al. Intrapartum GBS screening and antibiotic prophylaxis: a European consensus conference. J Matern Fetal Neonatal Med. 2015;28(7):766–782. doi:10.3109/14767058.2014.93480425162923
   PubMed Web of Science ®Google Scholar
• EdmondKM, KortsalioudakiC, ScottS, et al. Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis. Lancet. 2012;379(9815):547–556. doi:10.1016/S0140-6736(11)61651-622226047
   PubMed Web of Science ®Google Scholar
• SealeAC, Bianchi-JassirF, RussellNJ, et al. Estimates of the burden of group B Streptococcal disease worldwide for pregnant women, stillbirths, and children. Clin Infect Dis. 2017;65(suppl_2):S200–S219. doi:10.1093/cid/cix66429117332
   PubMed Web of Science ®Google Scholar
• LiuL, OzaS, HoganD, et al. Global, regional, and national causes of under-5 mortality in 2000–15: an updated systematic analysis with implications for the sustainable development goals. Lancet. 2016;388(10063):3027–3035. doi:10.1016/S0140-6736(16)31593-827839855
   PubMed Web of Science ®Google Scholar
• BakerCJ, BarrettFF. Transmission of group B streptococci among parturient women and their neonates. J Pediatr. 1973;83(6):919–925. doi:10.1016/S0022-3476(73)80524-44585831
   PubMed Web of Science ®Google Scholar
• GardnerSE, YowMD, LeedsLJ, ThompsonPK, MasonEO, ClarkDJ. Failure of penicillin to eradicate group B Streptococcal colonization in the pregnant woman. A couple study. Am J Obstet Gynecol. 1979;135(8):1062–1065. doi:10.1016/0002-9378(79)90737-3391044
   PubMed Web of Science ®Google Scholar
• GardnerSE, MasonEO, YowMD. Community acquisition of group B Streptococcus by infants of colonized mothers. Pediatrics. 1980;66(6):873–875.7005854
   PubMed Web of Science ®Google Scholar
• AnthonyBF, OkadaDM, HobelCJ. Epidemiology of group B Streptococcus: longitudinal observations during pregnancy. J Infect Dis. 1978;137(5):524–530. doi:10.1093/infdis/137.5.524351070
   PubMed Web of Science ®Google Scholar
• PassMA, GrayBM, KhareS, DillonHC. Prospective studies of group B streptococcal infections in infants. J Pediatr. 1979;95(3):437–443. doi:10.1016/S0022-3476(79)80531-4381620
   PubMed Web of Science ®Google Scholar
• EasmonCS, HastingsMJ, BlowersA, et al. Epidemiology of group B streptococci: one year’s experience in an obstetric and special care baby unit. Br J Obstet Gynaecol. 1983;90(3):241–246. doi:10.1111/j.1471-0528.1983.tb08617.x6338902
   PubMedGoogle Scholar
• DillonHC, KhareS, GrayBM. Group B streptococcal carriage and disease: a 6-year prospective study. J Pediatr. 1987;110(1):31–36. doi:10.1016/S0022-3476(87)80283-43540249
   PubMed Web of Science ®Google Scholar
• BoyerKM, GotoffSP. Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. N Engl J Med. 1986;314(26):1665–1669. doi:10.1056/NEJM1986062631426033520319
   PubMed Web of Science ®Google Scholar
• TuppurainenN, HallmanM. Prevention of neonatal group B streptococcal disease: intrapartum detection and chemoprophylaxis of heavily colonized parturients. Obstet Gynecol. 1989;73(4):583–587.2494620
   PubMed Web of Science ®Google Scholar
• GarlandSM, FliegnerJR. Group B streptococcus (GBS) and neonatal infections: the case for intrapartum chemoprophylaxis. Aust N Z J Obstet Gynaecol. 1991;31(2):119–122. doi:10.1111/j.1479-828X.1991.tb01797.x1930031
   PubMed Web of Science ®Google Scholar
• CanteyJB, BaldridgeC, JamisonR, ShanleyLA. Late and very late onset group B Streptococcus sepsis: one and the same?World J Pediatr. 2014;10(1):24–28. doi:10.1007/s12519-014-0450-824464660
   PubMed Web of Science ®Google Scholar
• BenitzWE, GouldJB, DruzinML. Risk factors for early-onset group B streptococcal sepsis: estimation of odds ratios by critical literature review. Pediatrics. 1999;103(6):e77. doi:10.1542/peds.103.6.e7710353974
   PubMed Web of Science ®Google Scholar
• NanduriSA, PetitS, SmelserC, et al. Epidemiology of invasive early-onset and late-onset group B Streptococcal disease in the United States, 2006 to 2015: multistate laboratory and population-based surveillance. JAMA Pediatr. 2019;173(3):224–233. doi:10.1001/jamapediatrics.2018.482630640366
   PubMed Web of Science ®Google Scholar
• WeindlingAM, HawkinsJM, CoombesMA, StringerJ. Colonisation of babies and their families by group B streptococci. Br Med J (Clin Res Ed). 1981;283(6305):1503–1505. doi:10.1136/bmj.283.6305.1503
   Web of Science ®Google Scholar
• WeismanLE, McKinneyL, VillalobosR. Systemic group B streptococcal disease in the neonate: characterization of an oral colonization model using the suckling rat. Microbiol Immunol. 1990;34(9):755–764. doi:10.1111/j.1348-0421.1990.tb01053.x2149405
   PubMed Web of Science ®Google Scholar
• VazMJ, PurrierSA, BonakdarM, ChambyAB, RatnerAJ, RandisTM. The impact of circulating antibody on group B Streptococcus intestinal colonization and invasive disease. Infect Immun. 2020;89(1):e00348–20. doi:10.1128/IAI.00348-2033077619
   PubMed Web of Science ®Google Scholar
• FilleronA, LombardF, JacquotA, et al. Group B streptococci in milk and late neonatal infections: an analysis of cases in the literature. Arch Dis Child Fetal Neonatal Ed. 2014;99(1):F41–7. doi:10.1136/archdischild-2013-30436223955469
   PubMed Web of Science ®Google Scholar
• BerardiA, RossiC, CretiR, et al. Group B streptococcal colonization in 160 mother-baby pairs: a prospective cohort study. J Pediatr. 2013;163(4):1099–104.e1. doi:10.1016/j.jpeds.2013.05.06423866714
   PubMed Web of Science ®Google Scholar
• Le DoareK, BellisK, FaalA, et al. SIgA, TGF-β1, IL-10, and TNFα in colostrum are associated with infant group B Streptococcus colonization. Front Immunol. 2017;8:1269. doi:10.3389/fimmu.2017.0126929109718
   PubMed Web of Science ®Google Scholar
• BerardiA, RossiC, LugliL, et al. Group B streptococcus late-onset disease: 2003–2010. Pediatrics. 2013;131(2):e361–8. doi:10.1542/peds.2012-123123296441
   PubMed Web of Science ®Google Scholar
• TaziA, PlainvertC, AnselemO, et al. Risk factors for infant colonization by hypervirulent CC17 group B Streptococcus: toward the understanding of late-onset disease. Clin Infect Dis. 2019;69(10):1740–1748. doi:10.1093/cid/ciz03330946447
   PubMed Web of Science ®Google Scholar
• SteereAC, AberRC, WarfordLR, et al. Possible nosocomial transmission of group B streptococci in a newborn nursery. J Pediatr. 1975;87(5):784–787. doi:10.1016/S0022-3476(75)80311-81102641
   PubMed Web of Science ®Google Scholar
• ParedesA, WongP, MasonEO, TaberLH, BarrettFF. Nosocomial transmission of group B Streptococci in a newborn nursery. Pediatrics. 1977;59(5):679–682.323810
   PubMed Web of Science ®Google Scholar
• Jauneikaite E, Kapatai G, Davies F, et al. Serial Clustering of Late-Onset Group B Streptococcal Infections in the Neonatal Unit: A Genomic Re-evaluation of Causality. Clin Infect Dis. 2018Aug 31;67(6):854–860. doi:10.1093/cid/ciy174
   Web of Science ®Google Scholar
• CollinSM, LambP, JauneikaiteE, et al. Hospital clusters of invasive group B Streptococcal disease: a systematic review. J Infect. 2019;79(6):521–527. doi:10.1016/j.jinf.2019.11.00831733233
   PubMed Web of Science ®Google Scholar
• PuopoloKM, LynfieldR, CummingsJJ. Management of infants at risk for group B Streptococcal disease. Pediatrics. 2019;144(2):e20191881. doi:10.1542/peds.2019-188131285392
   PubMed Web of Science ®Google Scholar
• BerardiA, LugliL, RossiC, et al. Infezioni da Streptococco B Della Regione Emilia Romagna. Neonatal bacterial meningitis. Minerva Pediatr. 2010;62(3 Suppl 1):51–54.
   PubMedGoogle Scholar
• LibsterR, EdwardsKM, LeventF, et al. Long-term outcomes of group B streptococcal meningitis. Pediatrics. 2012;130(1):e8–e15. doi:10.1542/peds.2011-345322689869
   PubMed Web of Science ®Google Scholar
• Kohli-LynchM, RussellNJ, SealeAC, et al. Neurodevelopmental impairment in children after group B Streptococcal disease worldwide: systematic review and meta-analyses. Clin Infect Dis. 2017;65(suppl_2):S190–S199. doi:10.1093/cid/cix66329117331
   PubMed Web of Science ®Google Scholar
• BertiniG, DaniC. Group B streptococcal late-onset sepsis with submandibular phlegmon in a premature infant after beginning of breast-feeding. J Matern Fetal Neonatal Med. 2008;21(3):213–215. doi:10.1080/1476705080192488618297577
   PubMed Web of Science ®Google Scholar
• BerardiA, CattelaniC, CretiR, et al. Group B streptococcal infections in the newborn infant and the potential value of maternal vaccination. Expert Rev Anti Infect Ther. 2015;13(11):1387–1399. doi:10.1586/14787210.2015.107912626295167
   PubMed Web of Science ®Google Scholar
• De CuetoM, SanchezMJ, SampedroA, et al. Timing of intrapartum ampicillin and prevention of vertical transmission of group B streptococcus. Obstet Gynecol. 1998;91:112–114. doi:10.1016/S0029-7844(97)00587-59464732
   PubMed Web of Science ®Google Scholar
• BoyerKM, GadzalaCA, KellyPD, et al. Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. III. Interruption of mother-to-infant transmission. J Infect Dis. 1983;148:810–816. doi:10.1093/infdis/148.5.8106355318
   PubMed Web of Science ®Google Scholar
• BerardiA, RossiC, BiasiniA, et al. Efficacy of intrapartum chemoprophylaxis less than 4 hours duration. J Matern Fetal Neonatal Med. 2011;24(4):619–625. doi:10.3109/14767058.2010.51134720828241
   PubMed Web of Science ®Google Scholar
• BerardiA, RossiC, GuidottiI, et al. Factors associated with intrapartum transmission of group B Streptococcus. Pediatr Infect Dis J. 2014;33:1211–1215. doi:10.1097/INF.000000000000043925037035
   PubMed Web of Science ®Google Scholar
• MadridL, SealeAC, Kohli-LynchM, et al. Infant group B Streptococcal disease incidence and serotypes worldwide: systematic review and meta-analyses. Clin Infect Dis. 2017;65(suppl_2):S160–S172. doi:10.1093/cid/cix656.29117326
   PubMed Web of Science ®Google Scholar
• MelinP, EfstratiouA. Group B streptococcal epidemiology and vaccine needs in developed countries. Vaccine. 2013;31(Suppl 4):D31–D42. doi:10.1016/j.vaccine.2013.05.01223973345
   PubMed Web of Science ®Google Scholar
• CretiR, ImperiM, BerardiA, et al.; Italian Neonatal GBS Infections Working Group. Neonatal group B Streptococcus infections: prevention strategies, clinical and microbiologic characteristics in 7 years of surveillance. Pediatr Infect Dis J. 2017;36(3):256–262. doi:10.1097/INF.000000000000141427870810
   PubMed Web of Science ®Google Scholar
• O’SullivanCP, LamagniT, PatelD, et al. Group B streptococcal disease in UK and Irish infants younger than 90 days, 2014–15: a prospective surveillance study. Lancet Infect Dis. 2019;19(1):83–90. doi:10.1016/S1473-3099(18)30555-330497953
   PubMed Web of Science ®Google Scholar
• LohrmannF, BergA, WickerE, et al. Prevalence of capsular serotype, pilus island distribution, and antibiotic resistance in pediatric and adult invasive group B Streptococcus isolates: data from a nationwide prospective surveillance study in germany. Pediatr Infect Dis J. 2021;40(1):76–82. doi:10.1097/INF.000000000000294333201062
   PubMed Web of Science ®Google Scholar
• JamrozyD, BijlsmaMW, de GoffauMC, et al. Increasing incidence of group B streptococcus neonatal infections in the Netherlands is associated with clonal expansion of CC17 and CC23. Sci Rep. 2020;10(1):9539. doi:10.1038/s41598-020-66214-332533007
   PubMed Web of Science ®Google Scholar
• DingY, WangY, HsiaY, RussellN, HeathPT. Systematic review and meta-analyses of incidence for group B Streptococcus disease in infants and antimicrobial resistance, China. Emerg Infect Dis. 2020;26(11):2651–2659. doi:10.3201/eid2611.18141433079042
   PubMed Web of Science ®Google Scholar
• KekicD, GajicI, OpavskiN, et al. Trends in molecular characteristics and antimicrobial resistance of group B streptococci: a multicenter study in Serbia, 2015–2020. Sci Rep. 2021;11(1):540. doi:10.1038/s41598-020-79354-333436658
   PubMed Web of Science ®Google Scholar
• ToyofukuM, MorozumiM, HidaM, et al. Effects of intrapartum antibiotic prophylaxis on neonatal acquisition of group B Streptococci. J Pediatr. 2017;190:169–173.e1. doi:10.1016/j.jpeds.2017.07.03929144242
   PubMed Web of Science ®Google Scholar
• Deshayes de CambronneR, FouetA, PicartA, et al. CC17 group B Streptococcus exploits integrins for neonatal meningitis development. J Clin Invest. 2021;131(5):e136737. doi:10.1172/JCI136737
   Web of Science ®Google Scholar
• AlmeidaA, Rosinski-ChupinI, PlainvertC, et al. Parallel evolution of group B Streptococcus hypervirulent clonal complex 17 unveils new pathoadaptive mutations. mSystems. 2017;2(5):e00074–17. doi:10.1128/mSystems.00074-1728904998
   PubMed Web of Science ®Google Scholar
• LachenauerCS, CretiR, MichelJL, MadoffLC. Mosaicism in the alpha-like protein genes of group B streptococci. Proc Natl Acad Sci USA. 2000;97(17):9630–9635. doi:10.1073/pnas.97.17.963010944228
   PubMed Web of Science ®Google Scholar
• GravekampC, RosnerB, MadoffLC, FischettiVA. Deletion of repeats in the alpha C protein enhances the pathogenicity of group B streptococci in immune mice. Infect Immun. 1998;66(9):4347–4354. doi:10.1128/IAI.66.9.4347-4354.19989712787
   PubMed Web of Science ®Google Scholar
• MadoffLC, MichelJL, GongEW, KlingDE, KasperDL. Group B streptococci escape host immunity by deletion of tandem repeat elements of the alpha C protein. Proc Natl Acad Sci USA. 1996;93:4131–4136. doi:10.1073/pnas.93.9.41318633028
   PubMed Web of Science ®Google Scholar
• WhelanF, LafitaA, GriffithsSC, et al. Defining the remarkable structural malleability of a bacterial surface protein Rib domain implicated in infection. Proc Natl Acad Sci USA. 2019;116(52):26540–26548. doi:10.1073/pnas.1911776116
   Web of Science ®Google Scholar
• AlmeidaA, VillainA, JoubrelC, et al. Whole-genome comparison uncovers genomic mutations between group B streptococci sampled from infected newborns and their mothers. J Bacteriol. 2015;197:3354–3366. doi:10.1128/JB.00429-1526283765
   PubMed Web of Science ®Google Scholar
• CampisiE, RosiniR, JiW, et al. Genomic analysis reveals multi-drug resistance clusters in group B Streptococcus CC17 hypervirulent isolates causing neonatal invasive disease in Southern Mainland China. Front Microbiol. 2016;7:1265. doi:10.3389/fmicb.2016.0126527574519
   PubMed Web of Science ®Google Scholar
• TeateroS, RamoutarE, McGeerA, et al. Clonal complex 17 group B Streptococcus strains causing invasive disease in neonates and adults originate from the same genetic pool. Sci Rep. 2016;6:20047. doi:10.1038/srep2004726843175
   PubMed Web of Science ®Google Scholar
• MartinsER, Pedroso-RoussadoC, Melo-CristinoJ, RamirezM; Portuguese Group for the Study of Streptococcal Infections. Streptococcus agalactiae causing neonatal infections in Portugal (2005–2015): diversification and emergence of a CC17/PI-2b multidrug resistant sublineage. Front Microbiol. 2017;8:499. doi:10.3389/fmicb.2017.0049928400757
   PubMed Web of Science ®Google Scholar
• PlainvertC, HaysC, TouakG, et al. Multidrug-resistant hypervirulent group B Streptococcus in neonatal invasive infections, France, 2007–2019. Emerg Infect Dis. 2020;26(11):2721–2724. doi:10.3201/eid2611.20166933079049
   PubMed Web of Science ®Google Scholar
• PharesCR, LynfieldR, FarleyMM, et al. Epidemiology of invasive group B streptococcal disease in the United States, 1999–2005. JAMA. 2008;299(17):2056–2065. doi:10.1001/jama.299.17.205618460666
   PubMed Web of Science ®Google Scholar
• SchuchatA, OxtobyM, CochiS, et al. Population-based risk factors for neonatal group B streptococcal disease: results of a cohort study in metropolitan Atlanta. J Infect Dis. 1990;162:672–677. doi:10.1093/infdis/162.3.6722201741
   PubMed Web of Science ®Google Scholar
• LinFY, WeismanLE, TroendleJ, AdamsK. Prematurity is the major risk factor for late-onset group B streptococcus disease. J Infect Dis. 2003;188(2):267–271. doi:10.1086/37645712854082
   PubMed Web of Science ®Google Scholar
• HamdanL, VandekarS, SpiekerAJ, et al. Epidemiological trends of racial differences in early- and late-onset group B Streptococcus disease in Tennessee. Clin Infect Dis. 2020;ciaa1511. doi:10.1093/cid/ciaa151133031511
   PubMed Web of Science ®Google Scholar
• LinFY, PhilipsJB, AzimiPH, et al. Level of maternal antibody required to protect neonates against early-onset disease caused by type 1a group B streptococcus: a multicenter, seroepidemiology study. J Infect Dis. 2001;184:1022–1028. doi:10.1086/32335011574917
   PubMed Web of Science ®Google Scholar
• FicaraM, PietrellaE, SpadaC. Changes of intestinal microbiota in early life. J Matern Fetal Neonatal Med. 2020;33:1036–1043. doi:10.1080/14767058.2018.150676030058404
   PubMed Web of Science ®Google Scholar
• BarbadoroP, MariglianoA, SaviniS, D’ErricoMM, ProsperoE. Group B Streptococcal sepsis: an old or ongoing threat?Am J Infect Control. 2011;39(8):e45–e48. doi:10.1016/j.ajic.2010.12.01721704424
   PubMed Web of Science ®Google Scholar
• BerardiA, GuidottiI, CretiR, et al. Two overlapping clusters of group B Streptococcus late-onset disease in a neonatal intensive care unit. Pediatr Infect Dis J. 2018;37(11):1160–1164. doi:10.1097/INF.000000000000198729561513
   PubMed Web of Science ®Google Scholar
• JordanHT, FarleyMM, CraigA, et al. Revisiting the need for vaccine prevention of late-onset neonatal group B streptococcal disease: a multistate, population-based analysis. Pediatr Infect Dis J. 2008;27(12):1057–1064. doi:10.1097/INF.0b013e318180b3b9.18989238
   PubMed Web of Science ®Google Scholar
• PintyeJ, SaltzmanB, WolfE, CrowellCS. Risk factors for late-onset group B Streptococcal disease before and after implementation of universal screening and intrapartum antibiotic prophylaxis. J Pediatric Infect Dis Soc. 2016;5(4):431–438. doi:10.1093/jpids/piv06726501472
   PubMed Web of Science ®Google Scholar
• MacFarquharJK, JonesTF, WoronAM, et al. Outbreak of late-onset group B Streptococcus in a neonatal intensive care unit. Am J Infect Control. 2010;38:283–288. doi:10.1016/j.ajic.2009.08.01120022407
   PubMed Web of Science ®Google Scholar
• JoubrelC, TaziA, SixA, et al. Group B streptococcus neonatal invasive infections, France 2007–2012. Clin Microbiol Infect. 2015;21:910–916. doi:10.1016/j.cmi.2015.05.03926055414
   PubMed Web of Science ®Google Scholar
• DangorZ, LalaSG, CutlandCL, et al. Burden of invasive group B Streptococcus disease and early neurological sequelae in South African infants. PLoS One. 2015;10:e0123014. doi:10.1371/journal.pone.012301425849416
   PubMed Web of Science ®Google Scholar
• HansenSM, UldbjergN, KillianM, SorensenUB. Dynamics of Streptococcus agalactiae colonization in women during and after pregnancy and in their infants. J Clin Microbiol. 2004;42:83–89. doi:10.1128/JCM.42.1.83-89.200414715736
   PubMed Web of Science ®Google Scholar
• BerardiA, Di FazzioG, GavioliS, et al. Universal antenatal screening for group B streptococcus in Emilia-Romagna. J Med Screen. 2011;18(2):60–64. doi:10.1258/jms.2011.01102321852697
   PubMed Web of Science ®Google Scholar
• FraserAM, BrockertJE, WardRH. Association of young maternal age with adverse reproductive outcomes. N Engl J Med. 1995;332:1113–1117. doi:10.1056/NEJM1995042733217017700283
   PubMed Web of Science ®Google Scholar
• EpalzaC, GoetghebuerT, HainautM, et al. High incidence of invasive group B streptococcal infections in HIV-exposed uninfected infants. Pediatrics. 2010;126(3):e631–e638. doi:10.1542/peds.2010-018320732944
   PubMed Web of Science ®Google Scholar
• CutlandCL, SchragSJ, ThigpenMC, et al. Increased risk for group B Streptococcus sepsis in young infants exposed to HIV, Soweto, South Africa, 2004–2008. Emerg Infect Dis. 2015;21:638–645. doi:10.3201/eid2104.14156225812061
   PubMed Web of Science ®Google Scholar
• ZimmermannP, GweeA, CurtisN. The controversial role of breast milk in GBS late-onset disease. J Infect. 2017;74(Suppl 1):S34–S40. doi:10.1016/S0163-4453(17)30189-528646960
   PubMed Web of Science ®Google Scholar
• KennyJF, ZeddAJ. Recurrent group B streptococcal disease in an infant associated with the ingestion of infected mother’s milk. J Pediatr. 1977;91:158–159. doi:10.1016/S0022-3476(77)80473-3327048
   PubMed Web of Science ®Google Scholar
• LanariM, SerraL, CavriniF, LiguoriG, SambriV. Late-onset group B streptococcal disease by infected mother’s milk detected by polymerase chain reaction. New Microbiol. 2007;30:253–254.17802903
   PubMed Web of Science ®Google Scholar
• ByrnePA, MillerC, JustusK. Neonatal group B streptococcal infection related to breast milk. Breastfeed Med. 2006;1:263–270. doi:10.1089/bfm.2006.1.26317661607
   PubMed Web of Science ®Google Scholar
• BingenE, DenamurE, Lambert-ZechovskyN, et al. Analysis of DNA restriction fragment length polymorphism extends the evidence for breast milk transmission in Streptococcus agalactiae late-onset neonatal infection. J Infect Dis. 1992;165:569–573. doi:10.1093/infdis/165.3.5691347059
   PubMed Web of Science ®Google Scholar
• DingerJ, MullerD, PargacN, SchwarzeR. Breast milk transmission of group B streptococcal infection. Pediatr Infect Dis J. 2002;21:567–568. doi:10.1097/00006454-200206000-0001712182384
   PubMed Web of Science ®Google Scholar
• PerezPF, DoréJ, LeclercM, et al. Bacterial imprinting of the neonatal immune system: lessons from maternal cells?Pediatrics. 2007;119(3):e724–e732. doi:10.1542/peds.2006-164917332189
   PubMed Web of Science ®Google Scholar
• KubınV, Mrastikova H, PaulovaM, MotlovaJ, Frane˘kJ. Group B Streptococci in the milk of lactating mothers. Zentralbl Bakteriol Mikrobiol Hyg A. 1987;265:210–217.3314258
   PubMedGoogle Scholar
• BurianovaI, PaulovaM, CermakP, JanotaJ. Group B streptococcus colonization of breast milk of group B streptococcus positive mothers. J Hum Lact. 2013;29:586–590. doi:10.1177/089033441347944823525584
   PubMed Web of Science ®Google Scholar
• Feildel-FournialC, LaunayE, CaillonJ, ThomasE, BoscherC, Gras-le GuenC. What is the optimal management for the asymptomatic twin after diagnosis of late-onset group B streptococcal disease?Arch Dis Child. 2019;104:401–405. doi:10.1136/archdischild-2018-316170
   Web of Science ®Google Scholar
• DangorZ, KhanM, KwatraG, et al. The association between breastmilk group B Streptococcal capsular antibody levels and late-onset disease in young infant. Clin Infect Dis. 2020;70:1110–1114.31056692
   PubMed Web of Science ®Google Scholar
• BizzarroMJ, JiangY, HussainN, GruenJR, BhandariV, ZhangH. The impact of environmental and genetic factors on neonatal late-onset sepsis. J Pediatr. 2011;158:234–238.e1. doi:10.1016/j.jpeds.2010.07.06020850766
   PubMed Web of Science ®Google Scholar
• EdwardsMS, JacksonCV, BakerCJ. Increased risk of group B streptococcal disease in twins. JAMA. 1981;245:2044–2046. doi:10.1001/jama.1981.033104500360197014940
   PubMed Web of Science ®Google Scholar
• MatsubaraK, HoshinaK, KondoM, et al. Group B streptococcal disease in infants in the first year of life: a nationwide surveillance study in Japan, 2011–2015. Infection. 2017;45:449–458. doi:10.1007/s15010-017-0995-228236250
   PubMed Web of Science ®Google Scholar